Biotite Private Limited
Founded in 2018 and headquartered in Jharkhand, India.
2018 | Koderma, Jharkhand (India) | Active
Biotite Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.90 M
- Company Age 7 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -100.00%
- Profit Growth -108.67%
- Ebitda -108.87%
- Net Worth -15.83%
- Total Assets -3.15%
About Biotite
Biotite Private Limited (BPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2018 (Seven years 14 days old ). Its registered office is in Koderma, Jharkhand, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Yadav, Sunita Kumari, Abhishek Sharma, and Three other members serve as directors at the Company.
Company Details
- Location
Koderma, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U14294JH2018PTC010984
- Company No.
010984
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Metals and Minerals
Who are the key members and board of directors at Biotite?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Yadav  | Director | 13-Feb-2018 | Current |
| Sunita Kumari | Director | 13-Feb-2018 | Current |
| Abhishek Sharma | Director | 13-Feb-2018 | Current |
| Sushila Devi | Director | 13-Feb-2018 | Current |
| Rashmee Bala | Director | 13-Feb-2018 | Current |
| Rajni Bala | Director | 13-Feb-2018 | Current |
Financial Performance of Biotite.
Biotite Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 108.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotite?
In 2023, Biotite had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotite?
Unlock and access historical data on people associated with Biotite, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotite, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotite's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.